Skip to content

Clinical Empirical Research of ARDS

Clinical Empirical Research of ARDS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05922826
Enrollment
200
Registered
2023-06-28
Start date
2023-06-18
Completion date
2026-06-01
Last updated
2023-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Mechanical Ventilation ARDS

Brief summary

According to the ARDS Berlin definition, patients with severe concurrent invasive mechanical ventilation were selected, and clinical data and prognosis were collected. Samples such as blood and balf were collected for analysis based on changes in the condition.

Interventions

None listed

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. Patients who meet the Berlin definition of ARDS and require invasive mechanical ventilation. ARDS diagnostic criteria: according to the Berlin definition, Chest radiograph shows patchy shadows in the lungs; Respiratory failure cannot be completely caused by heart failure or excessive fluid infusion 2. ARDS onset ≤ 3 days when included in the study 3. Patient PaO2/FiO2 ≤ 200mmHg when included in the study

Exclusion criteria

* 1\) Patients with intracranial hypertension, pleural fistula, pneumothorax, HIV, HBV, HCV 2\) Age\>85 years old or\<18 years old 3\) Pregnant patients 4\) Severe hemodynamic instability (vasopressor increase\>30% in the first 6 hours, or Norepinephrine\>0.5 mg kg/min) 5\) Patients unable to perform EIT ventilation and/or perfusion testing (unable to perform internal jugular vein catheterization, Hypernatremia, chest malformation, active implant device, unstable spinal injury or fracture, skin lesions opposite the EIT monitoring area) 6\) Patients with abnormal esophageal anatomical structure and inability to indwelling gastric tubes 7\) Disagreement for inclusion in this study

Design outcomes

Primary

MeasureTime frame
Overall Survival28 days

Countries

China

Contacts

Primary ContactLin Wang, doctor
wl1194079931@163.com15822048750

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026